Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib plus Jintiange capsules for symptomatic knee osteoarthritis
ChiCTR2400079541Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing celecoxib + Jintiange capsules with celecoxib + Jintiange placebo (2 arms). Primary endpoint: WOMAC score at Week 20. Started Jan 2024; status: recruiting.
02
Drugs
celecoxibjintiange
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400079541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079541.